Evidence mapPaperPMID 41744868Full record

Observational studyCurrent oncology (Toronto, Ont.)2026

Brain Tumor Care in Relation to Patient Age-An Observational Study Between Years 2016 and 2022 in a Nationwide Cohort in Germany.

Frederic Bold, Gerardo Rico Gonzalez, Rüdiger Gerlach, Oliver Heese, Steffen K Rosahl, Michael Stoffel, Juraj Kukolja, Frederick Palm, Emilia Machado Musri, Ali Allam and 5 more

Abstract readObservational Study
In one paragraph

Observational study in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Frederic BoldFaculty of Health Sciences Brandenburg, Medical School Theodor Fontane, Campus Bad Saarow, 15526 Bad Saarow, Germany.
Gerardo Rico GonzalezFaculty of Health Sciences Brandenburg, Medical School Theodor Fontane, Campus Bad Saarow, 15526 Bad Saarow, Germany.
Rüdiger GerlachDepartment of Neurosurgery, Helios Hospital Erfurt, 99089 Erfurt, Germany.
Oliver HeeseDepartment of Neurosurgery, Helios Hospital Schwerin, 19055 Schwerin, Germany.
Steffen K RosahlDepartment of Neurosurgery, Helios Hospital Erfurt, 99089 Erfurt, Germany.
Michael StoffelDepartment of Neurosurgery, Helios Hospital Krefeld, 47805 Krefeld, Germany.
Juraj KukoljaDepartment of Neurology, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany.ORCID 0000-0003-1569-3287
Frederick PalmDepartment of Neurology, Helios Hospital Schleswig, 24837 Schleswig, Germany.
Emilia Machado MusriFaculty of Health Sciences Brandenburg, Medical School Theodor Fontane, Campus Bad Saarow, 15526 Bad Saarow, Germany.ORCID 0000-0003-0750-6955
Ali AllamFaculty of Health Sciences Brandenburg, Medical School Theodor Fontane, Campus Bad Saarow, 15526 Bad Saarow, Germany.
Ralf KuhlenHelios Health Institute, 13125 Berlin, Germany.
Julius DenglerFaculty of Health Sciences Brandenburg, Medical School Theodor Fontane, Campus Bad Saarow, 15526 Bad Saarow, Germany.ORCID 0000-0002-6698-8600
Sven HohensteinClinical Trial Management & Real World Data, Helios Health Institute, 13125 Berlin, Germany.ORCID 0000-0002-9708-1593
Andreas BollmannClinical Trial Management & Real World Data, Helios Health Institute, 13125 Berlin, Germany.
Nora F DenglerFaculty of Health Sciences Brandenburg, Medical School Theodor Fontane, Campus Bad Saarow, 15526 Bad Saarow, Germany.

Funding

Helios Center for Research and Innovation HCRI ID 2021-0431
6 · The paper itself

Abstract

As societies continue to age, brain tumors increasingly affect older patients. Still, large-scale evidence on whether the relationship between age and brain tumor has been evolving over time is scarce. We examined longitudinal trends among different age groups of patients with brain tumors at 78 German hospitals. Two time periods were compared as follows: phase 1 (1 January 2016-31 December 2019; pre-pandemic) and phase 2 (1 January 2020-31 December 2022; pandemic). Patients were categorized as non-elderly (<65 years) or elderly (≥65 years), and according to 10-year age brackets. The clinical condition was quantified using the Elixhauser Comorbidity Index (ECI) and the Hospital Frailty Risk Score (HFRS). Among the 20,005 patients included, changes in characteristics of non-elderly/elderly patients over time behaved similarly, with improvements in ECI (19.3 to 18.4/15.2 to 14.3; each

Indexed as

Brain NeoplasmsAdultAgedAged, 80 and overAge FactorsCohort StudiesFemaleGermanyHumansMaleMiddle Agedagebrain tumor managementelderlyfrailty

Identifiers

PMID41744868
PMCPMC12939247

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.